The DOI matches its Crossref record; 114 of the 115 references it cites were found in a registry or an index.
Multiple Forms of Endocannabinoid and Endovanilloid Signaling Regulate the Tonic Control of GABA Release
Open accessAbstract
Persistent CB1 cannabinoid receptor activity limits neurotransmitter release at various synapses throughout the brain. However, it is not fully understood how constitutively active CB1 receptors, tonic endocannabinoid signaling, and its regulation by multiple serine hydrolases contribute to the synapse-specific calibration of neurotransmitter release probability. To address this question at perisomatic and dendritic GABAergic synapses in the mouse hippocampus, we used a combination of paired whole-cell patch-clamp recording, liquid chromatography/tandem mass spectrometry, stochastic optical reconstruction microscopy super-resolution imaging, and immunogold electron microscopy. Unexpectedly, application of the CB1 antagonist and inverse agonist AM251 [N-1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-N-1-piperidinyl-1H-pyrazole-3-carboxamide], but not the neutral antagonist NESS0327 [8-chloro-1-(2,4-dichlorophenyl)-N-piperidin-1-yl-5,6-dihydro-4H-benzo[2,3]cyclohepta[2,4-b]pyrazole-3-carboxamine], significantly increased synaptic transmission between CB1-positive perisomatic interneurons and CA1 pyramidal neurons. JZL184 (4-nitrophenyl 4-[bis(1,3-benzodioxol-5-yl)(hydroxy)methyl]piperidine-1-carboxylate), a selective inhibitor of monoacylglycerol lipase (MGL), the presynaptic degrading enzyme of the endocannabinoid 2-arachidonoylglycerol (2-AG), elicited a robust increase in 2-AG levels and concomitantly decreased GABAergic transmission. In contrast, inhibition of fatty acid amide hydrolase (FAAH) by PF3845 (N-pyridin-3-yl-4-[[3-[5-(trifluoromethyl)pyridin-2-yl]oxyphenyl]methyl]piperidine-1-carboxamide) elevated endocannabinoid/endovanilloid anandamide levels but did not change GABAergic synaptic activity. However, FAAH inhibitors attenuated tonic 2-AG increase and also decreased its synaptic effects. This antagonistic interaction required the activation of the transient receptor potential vanilloid receptor TRPV1, which was concentrated on postsynaptic intracellular membrane cisternae at perisomatic GABAergic symmetrical synapses. Interestingly, neither AM251, JZL184, nor PF3845 affected CB1-positive dendritic interneuron synapses. Together, these findings are consistent with the possibility that constitutively active CB1 receptors substantially influence perisomatic GABA release probability and indicate that the synaptic effects of tonic 2-AG release are tightly controlled by presynaptic MGL activity and also by postsynaptic endovanilloid signaling and FAAH activity. SIGNIFICANCE STATEMENT: Tonic cannabinoid signaling plays a critical role in the regulation of synaptic transmission. However, the mechanistic details of how persistent CB1 cannabinoid receptor activity inhibits neurotransmitter release have remained elusive. Therefore, electrophysiological recordings, lipid measurements, and super-resolution imaging were combined to elucidate those signaling molecules and mechanisms that underlie tonic cannabinoid signaling. The findings indicate that constitutive CB1 activity has pivotal function in the tonic control of hippocampal GABA release. Moreover, the endocannabinoid 2-arachidonoylglycerol (2-AG) is continuously generated postsynaptically, but its synaptic effect is regulated strictly by presynaptic monoacylglycerol lipase activity. Finally, anandamide signaling antagonizes tonic 2-AG signaling via activation of postsynaptic transient receptor potential vanilloid TRPV1 receptors. This unexpected mechanistic diversity may be necessary to fine-tune GABA release probability under various physiological and pathophysiological conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“there are additional reports of TRPV1 expression in the bed nucleus of the stria terminalis (BNST) (Puente et al., 2011), hippocampal dentate gyrus (Canduela et al., 2015; Lee et al., 2015; Puente et al., 2015) and hippocampal CA1 region (Lee et al., 2015) in postsynaptic terminals of both inhibitory (Canduela et al., 2015; Lee et al., 2015) and excitatory synapses (Puente et al., 2011; Puente et”
From The endocannabinoid system as a target for novel anxiolytic drugs (2017) · cites this paper as Lee et al., 2015
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sub-diffraction-limit imaging by stochastic optical reconstruction microscopy (STORM)
Rust, M., Bates, M., & Zhuang, X. (2006) · Nature Methods · doi:10.1038/nmeth929 · Cited by 7,823
Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide
Zygmunt, P. M., Petersson, J., Andersson, D. A., Chuang, H.-H., Sørgård, M., Di Marzo, V., Julius, D., & Högestätt, E. D. (1999) · Nature · doi:10.1038/22761 · Cited by 2,142
Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides
Cravatt, B. F., Giang, D. K., Mayfield, S. P., Boger, D. L., Lerner, R. A., & Gilula, N. B. (1996) · Nature · doi:10.1038/384083a0 · Cited by 2,125
Neuronal Diversity and Temporal Dynamics: The Unity of Hippocampal Circuit Operations
Klausberger, T., & Somogyi, P. (2008) · Science · doi:10.1126/science.1149381 · Cited by 2,050
A second endogenous cannabinoid that modulates long-term potentiation
Stella, N., Schweitzer, P., & Piomelli, D. (1997) · Nature · doi:10.1038/42015 · Cited by 1,496
Brain monoglyceride lipase participating in endocannabinoid inactivation
Dinh, T. P., Carpenter, D., Leslie, F. M., Freund, T. F., Katona, I., Sensi, S. L., Kathuria, S., & Piomelli, D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.152334899 · Cited by 1,373
Self-citationModulation of anxiety through blockade of anandamide hydrolysis
Kathuria, S., Gaetani, S., Fegley, D., Valiño, F., Duranti, A., Tontini, A., Mor, M., Tarzia, G., Rana, G. L., Calignano, A., et al. (2003) · Nature Medicine · doi:10.1038/nm803 · Cited by 1,293
Katona, I., Sperlágh, B., Sı́k, A., Käfalvi, A., Vizi, E. S., Mackie, K., & Freund, T. F. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-11-04544.1999 · Cited by 1,218
Self-citationEndocannabinoid Signaling and Synaptic Function
Castillo, P. E., Younts, T. J., Chávez, A. E., & Hashimotodani, Y. (2012) · Neuron · doi:10.1016/j.neuron.2012.09.020 · Cited by 1,191
A Comprehensive Profile of Brain Enzymes that Hydrolyze the Endocannabinoid 2-Arachidonoylglycerol
Blankman, J. L., Simon, G. M., & Cravatt, B. F. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2007.11.006 · Cited by 1,177
Bisogno, T., Howell, F., Williams, G., Minassi, A., Cascio, M. G., Ligresti, A., Matias, I., Schiano-Moriello, A., Paul, P., Williams, E.-J., et al. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200305129 · Cited by 1,039
Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects
Long, J. Z., Li, W., Booker, L., Burston, J. J., Kinsey, S. G., Schlosburg, J. E., Pavón, F. J., Serrano, A., Selley, D. E., Parsons, L. H., et al. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.129 · Cited by 954
Neuromodulation of neuronal circuits: back to the future
Marder, E. (2012) · Neuron · doi:10.1016/j.neuron.2012.09.010 · Cited by 904
Superresolution Imaging of Chemical Synapses in the Brain
Dani, A., Huang, B., Bergan, J. F., Dulac, C. G., & Zhuang, X. (2010) · Neuron · doi:10.1016/j.neuron.2010.11.021 · Cited by 748
Extrasynaptic GABAA Receptors: Their Function in the CNS and Implications for Disease
Brickley, S. G., & Módy, I. (2012) · Neuron · doi:10.1016/j.neuron.2011.12.012 · Cited by 695
Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system
Schlosburg, J. E., Blankman, J. L., Long, J. Z., Nomura, D. K., Pan, B., Kinsey, S. G., Nguyen, P. T., Ramesh, D., Booker, L., Burston, J. J., et al. (2010) · Nature Neuroscience · doi:10.1038/nn.2616 · Cited by 641
Multiple Functions of Endocannabinoid Signaling in the Brain
Katona, I., & Freund, T. F. (2012) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-062111-150420 · Cited by 630
Self-citationGulyas, A. I., Cravatt, B. F., Bracey, M. H., Dinh, T. P., Piomelli, D., Boscia, F., & Freund, T. F. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03428.x · Cited by 561
Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons
Twitchell, W., Brown, S., & Mackie, K. (1997) · Journal of Neurophysiology · doi:10.1152/jn.1997.78.1.43 · Cited by 544
Molecular Composition of the Endocannabinoid System at Glutamatergic Synapses
Katona, I., Urbán, G. M., Wallace, M., Ledent, C., Jung, K.-M., Piomelli, D., Mackie, K., & Freund, T. F. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.0309-06.2006 · Cited by 511
Self-citationThe probability of neurotransmitter release: variability and feedback control at single synapses
Branco, T., & Staras, K. (2009) · Nature reviews. Neuroscience · doi:10.1038/nrn2634 · Cited by 467
Bouaboula, M., Perachon, S., Milligan, L., Canat, X., Rinaldi, M. L., Portier, M., Barth, F., Calandra, B., Pecceu, F., Lupker, J. H., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.35.22330 · Cited by 463
Inverse agonism and neutral antagonism at cannabinoid CB1 receptors
Pertwee, R. G. (2004) · Life Sciences · doi:10.1016/j.lfs.2004.10.025 · Cited by 444
Discovery and Characterization of a Highly Selective FAAH Inhibitor that Reduces Inflammatory Pain
Ahn, K., Johnson, D. S., Mileni, M., Beidler, D., Long, J. Z., McKinney, M. K., Weerapana, E., Sadagopan, N., Liimatta, M., Smith, S. E., et al. (2009) · Chemistry & Biology · doi:10.1016/j.chembiol.2009.02.013 · Cited by 439
Principles: Receptor theory in pharmacology
Kenakin, T. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.02.012 · Cited by 412
Long, J. Z., Nomura, D. K., Vann, R. E., Walentiny, D. M., Booker, L., Jin, X., Burston, J. J., Sim‐Selley, L. J., Lichtman, A. H., Wiley, J. L., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909411106 · Cited by 405
Mechanisms of Cannabinoid Inhibition of GABAASynaptic Transmission in the Hippocampus
Hoffman, A. F., & Lupica, C. R. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-07-02470.2000 · Cited by 398
Gavva, N. R., Tamir, R., Qu, Y., Klionsky, L., Zhang, T. J., Immke, D. C., Wang, L., Zhu, D., Vanderah, T. W., Porreca, F., et al. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.079855 · Cited by 387
Postsynaptic TRPV1 triggers cell type–specific long-term depression in the nucleus accumbens
Grueter, B. A., Brasnjo, G., & Malenka, R. C. (2010) · Nature Neuroscience · doi:10.1038/nn.2685 · Cited by 361
Marsch, R., Foeller, E., Rammes, G., Bunck, M., Kössl, M., Holsboer, F., Zieglgänsberger, W., Landgraf, R., Lutz, B., & Wotjak, C. T. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3303-06.2007 · Cited by 359
Parvalbumin-Positive Basket Cells Differentiate among Hippocampal Pyramidal Cells
Lee, S.-H., Marchionni, I., Bezaire, M., Varga, C., Danielson, N., Lovett-Barron, M., Losonczy, A., & Soltesz, I. (2014) · Neuron · doi:10.1016/j.neuron.2014.03.034 · Cited by 358
Self-citationPeripheral Cannabinoid-1 Receptor Inverse Agonism Reduces Obesity by Reversing Leptin Resistance
Tam, J., Çınar, R., Liu, J., Godlewski, G., Wesley, D., Jourdan, T., Szanda, G., Mukhopadhyay, B., Chedester, L., Liow, J., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.07.002 · Cited by 356
Chávez, A. E., Chiu, C. Q., & Castillo, P. E. (2010) · Nature Neuroscience · doi:10.1038/nn.2684 · Cited by 348
Egertová, M., Giang, D. K., Cravatt, B. F., & Elphick, M. R. (1998) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.1998.0543 · Cited by 337
Yoshida, T., Fukaya, M., Uchigashima, M., Miura, E., Kamiya, H., Kano, M., & Watanabe, M. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.0054-06.2006 · Cited by 334
Self-citationChemical Probes of Endocannabinoid Metabolism
Blankman, J. L., & Cravatt, B. F. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.006387 · Cited by 327
Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum
Maccarrone, M., Rossi, S., Bari, M., Chiara, V. D., Fezza, F., Musella, A., Gasperi, V., Prosperetti, C., Bernardi, G., Finazzi‐Agrò, A., et al. (2008) · Nature Neuroscience · doi:10.1038/nn2042 · Cited by 306
Why do cannabinoid receptors have more than one endogenous ligand?
Di Marzo, V., & De Petrocellis, L. (2012) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2011.0382 · Cited by 290
FAAH genetic variation enhances fronto-amygdala function in mouse and human
Dincheva, I., Drysdale, A. T., Hartley, C. A., Johnson, D. C., Jing, D., King, E. C., Ra, S., Gray, J. M., Yang, R., DeGruccio, A. M., et al. (2015) · Nature Communications · doi:10.1038/ncomms7395 · Cited by 289
Huang, G. Z., & Woolley, C. S. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.035 · Cited by 288
Autism-Associated Neuroligin-3 Mutations Commonly Disrupt Tonic Endocannabinoid Signaling
Földy, C., Malenka, R. C., & Südhof, T. C. (2013) · Neuron · doi:10.1016/j.neuron.2013.02.036 · Cited by 287
Circuitry for associative plasticity in the amygdala involves endocannabinoid signaling
Azad, S. C., Monory, K., Marsicano, G., Cravatt, B. F., Lutz, B., Zieglgänsberger, W., & Rammes, G. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.2134-04.2004 · Cited by 263 · cited 2×
“, 2009a), emerging evidence indicates that specific forms of phasic and tonic endocannabinoid signaling at given brain circuit locations or under specific physiological conditions are mediated by anandamide (Azad et al., 2004; Kim and Alger, 2010; Huang and Woolley, 2012; Lerner and Kreitzer, 2012; Khlaifia et al., 20…”
BackgroundPawelzik, H., Hughes, D. I., & Thomson, A. M. (2002) · Journal of Comparative Neurology · doi:10.1002/cne.10118 · Cited by 262
Hillard, C. J. (2000) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(00)00051-4 · Cited by 261
Endocannabinoid-mediated retrograde modulation of synaptic transmission
Ohno‐Shosaku, T., & Kano, M. (2014) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2014.03.017 · Cited by 260
Presynaptic Modulation by Endocannabinoids
Lovinger, D. M. (2007) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-74805-2_14 · Cited by 247
Ludányi, A., Erőss, L., Czirják, S., Vajda, J., Halász, P., Watanabe, M., Palkovits, M., Maglóczky, Z., Freund, T. F., & Katona, I. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.4465-07.2008 · Cited by 241
Self-citationFukudome, Y., Ohno‐Shosaku, T., Matsui, M., Omori, Y., Fukaya, M., Tsubokawa, H., Taketo, M. M., Watanabe, M., Manabe, T., & Kano, M. (2004) · European Journal of Neuroscience · doi:10.1111/j.0953-816x.2004.03384.x · Cited by 238
Self-citationAmygdala FAAH and anandamide: mediating protection and recovery from stress
Gunduz-Cinar, O., Hill, M. N., McEwen, B. S., & Holmes, A. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.08.008 · Cited by 229
Cell-specific STORM super-resolution imaging reveals nanoscale organization of cannabinoid signaling
Dudok, B., Barna, L., Ledri, M., Szabó, S. I., Szabadits, E., Pintér, B., Woodhams, S. G., Henstridge, C. M., Balla, G. Y., Nyilas, R., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.3892 · Cited by 227
Self-citationLeterrier, C., Lainé, J., Darmon, M. C., Boudin, H., Rossier, J., & Lenkei, Z. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.5437-05.2006 · Cited by 208
Long-Term Plasticity of Endocannabinoid Signaling Induced by Developmental Febrile Seizures
Chen, K., Ratzliff, A., Hilgenberg, L. G. W., Gulyás, A. I., Freund, T. F., Smith, M., Dinh, T. P., Piomelli, D., Mackie, K., & Soltész, I. (2003) · Neuron · doi:10.1016/s0896-6273(03)00499-9 · Cited by 204
Lerner, T. N., & Kreitzer, A. C. (2012) · Neuron · doi:10.1016/j.neuron.2011.11.015 · Cited by 194
Vida, I., Halasy, K., Szinyei, C., Somogyi, P., & Buhl, E. H. (1998) · The Journal of Physiology · doi:10.1111/j.1469-7793.1998.755bv.x · Cited by 190
Neu, A. D., Földy, C., & Soltész, I. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.115691 · Cited by 190
Pan, X., Ikeda, S. R., & Lewis, D. L. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.6.1064 · Cited by 190
Hashimotodani, Y., Ohno‐Shosaku, T., & Kano, M. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.4159-06.2007 · Cited by 186
Endocannabinoid signalling: has it got rhythm?
Vaughn, L. K., Denning, G., Stuhr, K. L., de Wit, H., Hill, M. N., & Hillard, C. J. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00790.x · Cited by 176
Polymodal activation of the endocannabinoid system in the extended amygdala
Puente, N., Cui, Y., Lassalle, O., Lafourcade, M., Georges, F., Venance, L., Grandes, P., & Manzoni, O. J. (2011) · Nature Neuroscience · doi:10.1038/nn.2974 · Cited by 173
Nyíri, G., Cserép, C., Szabadits, E., Mackie, K., & Freund, T. F. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.01.026 · Cited by 172
Sullivan, J. (1999) · Journal of Neurophysiology · doi:10.1152/jn.1999.82.3.1286 · Cited by 172
Antistress Effect of TRPV1 Channel on Synaptic Plasticity and Spatial Memory
Li, H.-B., Mao, R., Zhang, J., Yang, Y., Cao, J., & Xu, L. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.02.020 · Cited by 165
Persistently active cannabinoid receptors mute a subpopulation of hippocampal interneurons
Losonczy, A., Biró, Á. A., & Nusser, Z. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0304752101 · Cited by 161
Pan, B., Wang, W., Zhong, P., Blankman, J. L., Cravatt, B. F., & Liu, Q.-S. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.2075-11.2011 · Cited by 160
Monoacylglycerols Activate TRPV1 – A Link between Phospholipase C and TRPV1
Zygmunt, P. M., Ermund, A., Movahed, P., Andersson, D. A., Simonsen, C., Jönsson, B., Blomgren, A., Birnir, B., Bevan, S., Eschalier, A., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081618 · Cited by 157
Chen, K., Neu, A. D., Howard, A. L., Földy, C., Echegoyen, J. C., Hilgenberg, L. G. W., Smith, M. J., Mackie, K., & Soltész, I. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.3966-06.2007 · Cited by 157
Reduction in endocannabinoid tone is a homeostatic mechanism for specific inhibitory synapses
Kim, J., & Alger, B. E. (2010) · Nature Neuroscience · doi:10.1038/nn.2517 · Cited by 149
Adenosine: setting the stage for plasticity
Dias, R. B., Rombo, D. M., Ribeiro, J. A., Henley, J. M., & Sebastião, A. M. (2013) · Trends in Neurosciences · doi:10.1016/j.tins.2012.12.003 · Cited by 145
Cope, D. W., Maccaferri, G., Márton, L. F., Roberts, J. D. B., Cobden, P. M., & Somogyi, P. (2002) · Neuroscience · doi:10.1016/s0306-4522(01)00440-7 · Cited by 144
Földy, C., Neu, A. D., Jones, M. V., & Soltész, I. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.4587-05.2006 · Cited by 142
Hentges, S. T., Low, M. J., & Williams, J. T. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.2769-05.2005 · Cited by 136
Zhu, P., & Lovinger, D. M. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.1148-05.2005 · Cited by 131
More surprises lying ahead. The endocannabinoids keep us guessing
Piomelli, D. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.07.026 · Cited by 128
Sumislawski, J. J., Ramikie, T. S., & Patel, S. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.166 · Cited by 124
Niehaus, J. L., Liu, Y., Wallis, K. T., Egertová, M., Bhartur, S. G., Mukhopadhyay, S., Shi, S., He, H., Selley, D. E., Howlett, A. C., et al. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.039263 · Cited by 121
Cristino, L., Starowicz, K., De Petrocellis, L., Morishita, J., Ueda, N., Guglielmotti, V., & Di Marzo, V. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2007.11.047 · Cited by 115
Lee, S.-H., Foldy, C., & Soltesz, I. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.6238-09.2010 · Cited by 114
Self-citationMoreira, F. A., de Aguiar, D. C., Terzian, A. L. B., Guimarães, F. S., & Wotjak, C. T. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.08.046 · Cited by 113
Nissen, W., Szabo, A., Somogyi, J., Somogyi, P., & Lamsa, K. P. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.3481-09.2010 · Cited by 112
Oliet, S. H. R., Baimoukhametova, D. V., Piet, R., & Bains, J. S. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2676-06.2007 · Cited by 107 · cited 4×
“, 2012) and have an essential function in the tonic control of neurotransmitter release (Losonczy et al., 2004; Hentges et al., 2005; Zhu and Lovinger, 2005; Neu et al., 2007; Oliet et al., 2007).”
BackgroundInfluentialCircadian rhythm of circulating levels of the endocannabinoid 2-arachidonoylglycerol
Hanlon, E. C., Tasali, E., Leproult, R., Stuhr, K. L., Doncheck, E., de Wit, H., Hillard, C. J., & Van Cauter, E. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3455 · Cited by 101
Uchigashima, M., Yamazaki, M., Yamasaki, M., Tanimura, A., Sakimura, K., Kano, M., & Watanabe, M. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.5665-10.2011 · Cited by 97
Self-citationSzabo, G. G., Lenkey, N., Holderith, N. B., Andrási, T., Nusser, Z., & Hájos, N. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.0247-14.2014 · Cited by 92
Ruiu, S., Pinna, G. A., Marchese, G., Mussinu, J., Saba, P., Tambaro, S., Casti, P., Vargiu, R., & Pani, L. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.049924 · Cited by 91
Serrano, A., Rivera, P., Pavón, F. J., Decara, J. M., Suárez, J., de Fonseca, F. R., & Parsons, L. H. (2011) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2011.01686.x · Cited by 86
Roberto, M., Cruz, M. T., Bajo, M., Siggins, G. R., Parsons, L. H., & Schweitzer, P. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.70 · Cited by 85
Alger, B. E. (2012) · The Journal of Physiology · doi:10.1113/jphysiol.2011.220855 · Cited by 82
Mato, S., Pazos, Á., & Valdizán, E. M. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01575-3 · Cited by 80
Neutral antagonism at the cannabinoid 1 receptor: a safer treatment for obesity
Meye, F. J., Trezza, V, Vanderschuren, L. J. M. J., Ramakers, G. M. J., & Adan, R. A. H. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.145 · Cited by 76
You, I., Jung, Y., Kim, M., Kwon, S., Hong, S., Lee, S., & Jang, C. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.10.013 · Cited by 73
Self-citationTakács, V. T., Szőnyi, A., Freund, T. F., Nyíri, G., & Gulyás, A. I. (2014) · Brain Structure and Function · doi:10.1007/s00429-013-0692-6 · Cited by 71
Ali, A. B., & Todorova, M. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07165.x · Cited by 66
Voltage drives diverse endocannabinoid signals to mediate striatal microcircuit-specific plasticity
Mathur, B. N., Tanahira, C., Tamamaki, N., & Lovinger, D. M. (2013) · Nature Neuroscience · doi:10.1038/nn.3478 · Cited by 60
Chávez, A. E., Hernández, V. M., Rodenas-Ruano, A., Chan, C. S., & Castillo, P. E. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.3635-14.2014 · Cited by 59
D’Antona, A. M., Ahn, K. H., & Kendall, D. A. (2006) · Biochemistry · doi:10.1021/bi060067k · Cited by 59
Thibault, K., Carrel, D., Bonnard, D., Gallatz, K., Simon, A., Biard, M., Pezet, S., Palkovits, M., & Lenkei, Z. (2012) · Cerebral Cortex · doi:10.1093/cercor/bhs240 · Cited by 59
Cannabinoid Receptor–Interacting Protein 1a Modulates CB1 Receptor Signaling and Regulation
Smith, T. H., Blume, L. C., Straiker, A. J., Cox, J. O., David, B. G., McVoy, J. R. S., Sayers, K. W., Poklis, J. L., Abdullah, R. A., Egertová, M., et al. (2015) · Molecular Pharmacology · doi:10.1124/mol.114.096495 · Cited by 56
Cannabinoid signaling in inhibitory autaptic hippocampal neurons
Straiker, A. J., & Mackie, K. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.06.004 · Cited by 52
Lenkey, N., Kirizs, T., Holderith, N., Máté, Z., Szabó, G., Vizi, E. S., Hájos, N., & Nusser, Z. (2015) · Nature Communications · doi:10.1038/ncomms7557 · Cited by 45
Changing the tune: plasticity and adaptation of retrograde signals
Iremonger, K. J., Cusulin, J. I. W., & Bains, J. S. (2013) · Trends in Neurosciences · doi:10.1016/j.tins.2013.04.007 · Cited by 43
Dvorzhak, A., Semtner, M., Faber, D. S., & Grantyn, R. (2012) · The Journal of Physiology · doi:10.1113/jphysiol.2012.241018 · Cited by 42
Musella, A., Chiara, V. D., Rossi, S., Cavasinni, F., Castelli, M., Cantarella, C., Mataluni, G., Bernardi, G., & Centonze, D. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.02.058 · Cited by 41
Functional diversity on synaptic plasticity mediated by endocannabinoids
Cachope, R. (2012) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2011.0386 · Cited by 37
Pardini, M., Krüeger, F., Koenigs, M. R., Raymont, V., Hodgkinson, C. A., Zoubak, S., Goldman, D. A., & Grafman, J. H. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.1 · Cited by 35
Mutations in the ‘DRY’ motif of the CB1 cannabinoid receptor result in biased receptor variants
Gyombolai, P., Tóth, A. D., Tímár, D., Turu, G., & Hunyady, L. (2014) · Journal of Molecular Endocrinology · doi:10.1530/jme-14-0219 · Cited by 34
Puente, N., Reguero, L., Elezgarai, I., Canduela, M. J., Mendizabal‐Zubiaga, J., Ramos, A., Fernández‐Espejo, E., & Grandes, P. (2014) · Brain Structure and Function · doi:10.1007/s00429-014-0711-2 · Cited by 33
Szabo, G. G., Papp, O. I., Máté, Z., Szabó, G., & Hájos, N. (2014) · Hippocampus · doi:10.1002/hipo.22330 · Cited by 31
Melis, M., Greco, B., & Tonini, R. (2014) · European Journal of Neuroscience · doi:10.1111/ejn.12501 · Cited by 31
Activation-dependent plasticity of polarized GPCR distribution on the neuronal surface
Simon, A., Loverdo, C., Gaffuri, A.-L., Urbanski, M., Ladarré, D., Carrel, D., Rivals, I., Leterrier, C., Bénichou, O., Dournaud, P., et al. (2013) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjt014 · Cited by 29
Brain region‐specific changes in N‐acylethanolamine contents with time of day
Liedhegner, E. S., Sasman, A., & Hillard, C. J. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12495 · Cited by 25
Ladarré, D., Roland, A. B., Biedzinski, S., Ricobaraza, A., & Lenkei, Z. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00426 · Cited by 23
Khlaifia, A., Farah, H., Gackière, F., & Tell, F. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.1028-13.2013 · Cited by 20
Horváth, E., Woodhams, S. G., Nyilas, R., Henstridge, C. M., Kano, M., Sakimura, K., Watanabe, M., & Katona, I. (2014) · European Journal of Neuroscience · doi:10.1111/ejn.12470 · Cited by 18
Self-citationKallendrusch, S., Hobusch, C., Ehrlich, A., Nowicki, M., Ziebell, S., Bechmann, I., Geißlinger, G., Koch, M., & Dehghani, F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051208 · Cited by 12
Cited by
Sorted by citations
Hippocampal GABAergic Inhibitory Interneurons
Pelkey, K. A., Chittajallu, R., Craig, M. T., Tricoire, L., Wester, J. C., & McBain, C. J. (2017) · Physiological Reviews · doi:10.1152/physrev.00007.2017 · Cited by 889
Cannabidiol as a Potential Treatment for Anxiety Disorders
Blessing, E., Steenkamp, M. M., Manzanares, J., & Marmar, C. R. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0387-1 · Cited by 752
Ligresti, A., PETROCELLIS, L. D., & Marzo, V. D. (2016) · Physiological Reviews · doi:10.1152/physrev.00002.2016 · Cited by 505
CB1 Receptor Signaling in the Brain: Extracting Specificity from Ubiquity
Busquets-García, A., Bains, J. S., & Marsicano, G. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.206 · Cited by 365
The cannabinoid system and pain
Woodhams, S. G., Chapman, V., Finn, D. P., Hohmann, A. G., & Neugebauer, V. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.06.015 · Cited by 285
Metadata
- Authors
- Lee, S.-H., Ledri, M., Toth, B., Marchionni, I., Henstridge, C. M., Dudok, B., Kenesei, K., Barna, L., Szabo, S. I., Renkecz, T., Oberoi, M., Watanabe, M., Limoli, C. L., Horvai, G., Soltesz, I., & Katona, I.
- Affiliations
- University of California, Irvine (US)
- HUN-REN Institute of Experimental Medicine (HU)
- Semmelweis University (HU)
- Budapest University of Technology and Economics (HU)
- Hokkaido University (JP)
- ORCID
- Venue
- Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2015-07-08
- Volume
- 35
- Issue
- 27
- Pages
- 10039-10057
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC4495235
- OpenAlex
- W1892287994
- Cited by
- 133
- References
- 115
- Citations by year
- 2026: 1 · 2025: 10 · 2024: 6 · 2023: 6 · 2022: 18 · 2021: 18 · 2020: 8 · 2019: 4 · 2018: 13 · 2017: 23 · 2016: 19 · 2015: 6
- FWCI
- 14.65
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- Journal of Neuroscience (publishedVersion, cc-by)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Padua Research Archive (University of Padova) (submittedVersion, other-oa)
- Discovery Research Portal (University of Dundee) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
- Padua Research Archive (University of Padova) (submittedVersion)
- Funders
- National Aeronautics and Space Administration (NNX10AD59G, NNX15AI22G)
- Wellcome Trust (090946)
- Magyar Tudományos Akadémia
- National Institutes of Health (CA-62203, NS35915)
- University of California, Irvine (CA-62203)
- National Cancer Institute (CA 62203, P30CA062203)
- National Institute of General Medical Sciences (GM-69337, T34GM069337)
- National Institute of Neurological Disorders and Stroke (R29NS035915, R01NS035915, NS-35915, R37NS035915)
- FP7 Ideas: European Research Council (243153)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- endocannabinoid signaling, CB1 receptor, tonic inhibition, GABA release, 2-arachidonoylglycerol, anandamide, monoacylglycerol lipase, fatty acid amide hydrolase, TRPV1, presynaptic inhibition, hippocampus, CA1 pyramidal neurons
- MeSH terms
- Animals, Arachidonic Acids, Enzyme Inhibitors, Female, gamma-Aminobutyric Acid, Glycerides, Hippocampus, Male, Mice, Inbred C57BL, Mice, Transgenic, Neurons, Piperidines, Pyrazoles, Pyridines, Synapses, Signal Transduction, Receptor, Cannabinoid, CB1, TRPV Cation Channels, Mice, Inhibitory Postsynaptic Potentials, Cannabinoid Receptor Modulators, Endocannabinoids
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review